ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Brainstorm Health: Antibiotic Resistance, Stem Cell Skin Regeneration, Postpartum Depression Drug – Fortune

FortuneBrainstorm Health: Antibiotic Resistance, Stem Cell Skin Regeneration, Postpartum Depression DrugFortuneDuring the next 12 months, the CDC estimates that at least 2 million illnesses and 23,000 deaths will be caused by bacterial or fungal infect… Continue reading

2017-11-09 Michael Zand NEWS

FDA OKs Merck drug that prevents infection post-stem cell transplant – Business Insider

Continue reading

2017-11-09 Michael Zand NEWS

Financial Comparison: Editas Medicine (EDIT) & Its Peers – StockNewsTimes

WeeklyHubFinancial Comparison: Editas Medicine (EDIT) & Its PeersStockNewsTimesCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or CRISPR from Prevotella and Francisella… Continue reading

2017-11-09 Michael Zand NEWS

Financial Comparison: Editas Medicine (EDIT) & Its Peers – StockNewsTimes

WeeklyHubFinancial Comparison: Editas Medicine (EDIT) & Its PeersStockNewsTimesCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or CRISPR from Prevotella and Francisella… Continue reading

2017-11-09 Michael Zand NEWS

Letermovir (Prevymis) Okayed for Stem Cell Transplant Infection – Medscape


Medscape

FDA OKs Merck drug that prevents infection post-stem cell transplant
Business Insider
(Reuters) – Merck & Co Ltd’s drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug Administration, the drugmaker said on Thursday. Merck said the drug, which is expected to be …
Letermovir (Prevymis) Okayed for Stem Cell Transplant InfectionMedscape
FDA Approves Prevymis to Prevent CMV Among Stem Cell Transplant PatientsInfectious Disease Special Edition

all 15 news articles »

Continue reading

2017-11-09 Michael Zand NEWS

Gene Therapy 2016-2026 – Latest Technologies, Markets and Companies Report – Research and Markets – Business Wire (press release)

Gene Therapy 2016-2026 – Latest Technologies, Markets and Companies Report – Research and MarketsBusiness Wire (press release)The markets for gene therapy have been difficult to estimate as there only a few approved gene therapy products Gene therapy m… Continue reading

2017-11-09 Michael Zand NEWS

Endometrial Cancer Enters Immunotherapy Age – OncLive

OncLiveEndometrial Cancer Enters Immunotherapy AgeOncLiveThe tumor-site agnostic FDA approval of the PD-1 inhibitor pembrolizumab (Keytruda) for patients with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors has … Continue reading

2017-11-09 Michael Zand NEWS

Endometrial Cancer Enters Immunotherapy Age – OncLive

OncLiveEndometrial Cancer Enters Immunotherapy AgeOncLiveThe tumor-site agnostic FDA approval of the PD-1 inhibitor pembrolizumab (Keytruda) for patients with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors has … Continue reading

2017-11-09 Michael Zand NEWS
  • 1
  • …
  • 916
  • 917
  • 918
  • 919
  • 920
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Medscape

Letermovir (Prevymis) Okayed for Stem Cell Transplant Infection
Medscape
In allogeneic HSCTs, stem cells are derived from another person’s bone marrow, as opposed to the patient’s own. The FDA puts the number of allogeneic HSCTs performed each year at more than 27,000 worldwide; roughly 8500 are performed each year in …
Prevymis Approved to Prevent Virus in Patients Receiving Stem Cell TransplantsCuretoday.com
FDA Approves Prevymis to Prevent CMV Among Stem Cell Transplant PatientsPharmacy Practice News

all 22 news articles »